Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $11.13 Analyst target: $14.82 Upside: 33.15%
Absci Corp (ABSI) is a cutting-edge biotechnology company that utilizes a proprietary AI-driven platform to revolutionize drug discovery and development. By facilitating the rapid generation of high-quality proteins and therapeutic candidates, Absci effectively shortens development timelines and lowers associated costs, establishing itself as a key innovator within the biopharmaceutical sector. The company's robust pipeline, complemented by strategic partnerships, underscores its commitment to advancing next-generation therapies that address critical medical needs and improve patient outcomes.
See the full interactive analysis & chart →Informational only — not investment advice.